서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 40 of 50

Issue DateTitle / Author(s) / CitationFileAltmetrics
2000
Distribution of JL1 antigen and cytotoxicity of gelonin-JL1 antibody immunotoxin
link
2002
Preventive and therapeutic effects of oral tolerance in a murine model of asthma
link
2003
알레르기 비염 마우스 모델에서 CpG oligodeoxynucleotide의 투여에 의한 알레르기 반응의 억제
link
2003
전이성 B16F10 흑색종 모델에서 동종 종양세포 항원을 탑재한 수지상세포 백신의 면역치료 효과
link
2004
신경모세포종에서 동종 종양항원을 탑재한 수지상세포 면역요법
link
2006-10
Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma
link
2007-05
Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
link
2007-05
Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
link
2007-06
Tumor specificity and in vivo targeting of an antibody against exon 9 deleted E-cadherin in gastric cancer
DOI
2009-01
Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death
DOI
2009-03
Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells

Shin, Jin-Young; Yoon, Il-Hee; Kim, Jung-Sik; Kim, Bongi; Park, Chung-Gyu

Cell Immunol. 2009;256(1-2):72-8. Epub 2009 Feb 26.

link
2009-09
Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites

Chang, Hyun; Han, Doo Hee; Mo, Ji-hun; Kim, Jeong-Whun; Lee, Chul Hee; Rhee, Chae-Seo; Min, Yang-Gi; Kim, Dong-Young

CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY; Vol.2 3; 136-140

view fileDOI
2009-10
The Effect of CpG-Oligodeoxynucleotides with Different Backbone Structures and 3 ` Hexameric Deoxyriboguanosine Run Conjugation on the Treatment of Asthma in Mice
view fileDOI
2010-09
Efficacy of Dendritic Cells Matured Early with OK-432 (Picibanil®), Prostaglandin E(2), and Interferon-α as a Vaccine for a Hormone Refractory Prostate Cancer Cell Line
view fileDOI
2010-11
Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN
DOI
2011-02
방광암에서 유전자변형 혈관내피세포를 이용한 항암백신과 imatinib의 병합요법
link
2011-08
Does immunotherapy of viral warts provide beneficial effects when it is combined with conventional therapy?

Choi, Jae Woo; Cho, Soyun; Lee, Jong Hee

Annals of Dermatology, Vol.23 No.3, pp. 282-287

view fileDOI
2011-08
Does Immunotherapy of Viral Warts Provide Beneficial Effects When It Is Combined with Conventional Therapy?

Choi, Jae Woo; Cho, Soyun; Lee, Jong Hee

Annals of Dermatology, Vol.23 No.3, pp.282-287

DOI
2017-08
Development of Immunocytokine Based on Human PD-L1 Antibody and Interferon-β-1b Mutein
view file
2017-08
Scientific Advances in Thoracic Oncology 2016
DOI
2018-02
Anti-tumorigenic Activity of Human Cysteinyl-tRNA Synthetase via Immune Stimulation
view file
2018-03
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody
DOI
2018-05
Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives
DOI
2018-10
Biodegradable polymeric nanocarrier-based immunotherapy in hepatitis vaccination

Hong, Seo Jin; Ahn, Min Hye; Lee, Yong Woo; Pal, Sukdeb; Sangshetti, Jaiprakash; Arote, Rohidas B.

Advances in Experimental Medicine and Biology, Vol.1078, pp.303-320

DOI
2019-01
Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors
DOI
2019-03
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
view fileDOI
2019-08
Improvement of Purification efficiency by site-directed mutagenesis in interferon beta mutein fusion antibody
view filelink
2019-08
Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies
view fileDOI
2019-09
First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis
DOI
2019-10
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC
DOI
2020
Application of Stromal Vascular Fractions from Fat Tissues to Improve Dendritic Cell-Mediated Immune Responses
view filelink
2020
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma
DOI
2020-04
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies
DOI
2021-02
The combination of photodynamic therapy using phthalocyanin/albumin nano complex with immunotherapy in breast cancer model.
link
2021-02
A2A 아데노신 수용체 길항제의 구조-활성 상관관계에 관한 연구
link
2021-06
Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues
DOI
2021-06
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy
DOI
2021-07
Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer
DOI
2021-09
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer
DOI
2021-12
A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors
DOI
1 2